COMMUNIQUÉS West-GlobeNewswire

A.D.A.M. Innovations Expands GeneAI Forecast With New Chronic Disease Risk Assessment Models and Connected Biomarker Integration
16/09/2026
New models for asthma, atopic dermatitis and chronic obstructive pulmonary disease (COPD) expand GeneAI Forecast to 18 conditions, alongside resting heart rate integration from health apps and wearable devices. TOKYO, [...]
DLH Secures Follow-On NHLBI IT Services Award Valued at Up to $43.7 Million
16/09/2026
ATLANTA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today [...]
Cuprina Holdings (Cayman) Limited Announces Pricing of $4.97 million Public Offering
16/09/2026
SINGAPORE, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited ( Nasdaq: CUPR ) (“ Cuprina ” or “ the Company ”), a biomedical company developing and marketing products for the chronic wounds, [...]
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
16/09/2026
Health Canada-authorized trial to evaluate efficacy and safety of two sessions of MDMA-assisted therapy in up to 100 veterans and frontline workers VANCOUVER, British Columbia, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Optimi [...]
Notice of Annual General Meeting 2026
16/09/2026
Notice of Annual General Meeting 2026 ANNOUNCEMENT NO. 314 16 September 2026 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 8 October 2026 at 5.30 p [...]
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
16/09/2026
Milestone follows FDA clearance of MAIA’s amended investigational new drug (IND) submission highlighting improved manufacturing capabilities and efficiencies U.S. expansion is funded by a $2.3 million NIH grant to MAIA [...]
VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
16/09/2026
New data presented in Vienna highlights long-term repeat-dose modeling, mechanistic GI barrier profiling, and deconvolution of payload- and linker-dependent toxicities for complex modalities SAN DIEGO, Sept. 16, 2026 ( [...]
Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation
16/09/2026
September 16, 2026 SYMPHONY receives ITEA’s highest excellence award for connected healthcare ecosystems AI FORSchung is recognized for innovation in AI-powered fiber-optic sensing Amsterdam, the Netherlands – Royal [...]
R1 Expands Phare OS with Phare UM, Bringing Real-Time Payer Risk Intelligence to Utilization Management
16/09/2026
The Guthrie Clinic is Among the First Health Systems Adopting the New AI-enabled Solution to Identify Clinical Status Risk Earlier and Reduce Avoidable Medical Necessity Denials CHICAGO, Sept. 16, 2026 (GLOBE NEWSWIRE [...]
Syneos Health and Tufts CSDD Study Shows Clinical Trial Performance Depends More on Operating Model Design Than Sourcing Strategy
16/09/2026
Data From 13 Leading Pharmaceutical Companies Points to Execution, Governance and Partner Coordination as Key Drivers of Trial Performance MORRISVILLE, N.C., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Syneos Health®, a leading [...]
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
16/09/2026
SALT LAKE CITY, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Vishal Sikri has been promoted to [...]
Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale
16/09/2026
Six years after Seer’s foundational Nature Communications paper, researchers across three continents have built a growing body of evidence demonstrating the power of deep, unbiased proteomics across genetics, aging, [...]
Novo and Anthropic will collaborate to advance drug discovery with Claude
16/09/2026
Collaboration aims to help Novo discover and develop new medicines faster Novo will use Anthropic models and Claude Science to advance scientific reasoning for Research and Development (R&D) and agentic software [...]
Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care
16/09/2026
L ong-acting inject ables (LAIs) offer an opportunity to improve adherence and potential outcomes for patients with schizophrenia LongActingImpact.com is a new resource center designed to support clinicians in having [...]
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
16/09/2026
BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients [...]
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
16/09/2026
WILMINGTON, Del., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that, on September 10, 2026, it received a letter from the Listing Qualifications Department [...]
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
16/09/2026
New digital technologies, including Synchrony and SynX, will be featured at HRX Stereotaxis CEO to join main-stage panel on Autonomous EP Systems ST. LOUIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a [...]
ESA Letter in Utah: RealESALetter.com Gains Recognition Among Utah Residents
16/09/2026
SALT LAKE CITY, UT, Sept. 16, 2026 (GLOBE NEWSWIRE) -- RealESALetter.com connects Utah residents with licensed mental health professionals for individualized emotional support animal (ESA) evaluations and documentation [...]
Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®
16/09/2026
CLEVELAND, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced [...]

Pages